Maintenance work on the ZORA database servers is scheduled for Thursday 25th July 2019 from 19:00-20:00. During this period ZORA and JDB will not be available. Thank you for your understanding.
Rieder, F; Bettenworth, D; Ma, C; Parker, C E; Williamson, L A; Nelson, S A; van Assche, G; Di Sabatino, A; Bouhnik, Y; Stidham, R W; Dignass, A; Rogler, G; Taylor, S A; Stoker, J; Rimola, J; Baker, M E; Fletcher, J G; Panes, J; Sandborn, W J; Feagan, B G; Jairath, V (2018). An expert consensus to standardise definitions, diagnosis and treatment targets for anti-fibrotic stricture therapies in Crohn's disease. Alimentary Pharmacology & Therapeutics, 48(3):347-357.
Lalaoui, N; Hänggi, K; Brumatti, G; Chau, D; Nguyen, N Y N; Vasilikos, L; Spilgies, L M; Heckmann, D A; Ma, C; Ghisi, M; Salmon, J M; Matthews, G M; de Valle, E; Moujalled, D M; Menon, M B; Spall, S K; Glaser, S P; Richmond, J; Lock, R B; Condon, S M; Gugasyan, R; Gaestel, M; Guthridge, M; Johnstone, R W; Munoz, L; Wei, A; Ekert, P G; Vaux, D L; Wong, W Wei-Lynn; Silke, J (2016). Targeting p38 or MK2 enhances the anti-leukemic activity of smac-mimetics. Cancer Cell, 29(2):145-158.